Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
about
Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosisGenetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.Neurodevelopment in schizophrenia: the role of the wnt pathways.Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.GSK-3: Functional Insights from Cell Biology and Animal Models.Schizophrenia as a network disease: disruption of emergent brain function in patients with auditory hallucinationsLithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorderIncreased serum levels of apoptosis in deficit syndrome schizophrenia patients: a preliminary studyGlycogen synthase kinase 3 substrates in mood disorders and schizophrenia.Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders.Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder.Functional Network Disruptions in Schizophrenia.Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.New organometallic imines of rhenium(i) as potential ligands of GSK-3β: synthesis, characterization and biological studies.Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.
P2860
Q24187709-3A7CF413-4244-43DC-AE31-86F2163CA9AAQ30408186-0E968469-CCD6-4B28-BBEC-7CF29A44833AQ30442237-DD116A4C-7386-4BD0-9D44-6BB562835E70Q30454958-3BE17F0E-F186-4BBB-B6C2-EC9B1CBE593FQ30472813-57824DAC-2A85-4A46-BF70-2B8CF9280E41Q34561987-89A53AE8-83BD-4F66-9FD1-2A5CDFE92D09Q36480123-D9DFCDC2-A465-420C-9942-3BE0EC3FB030Q36956508-2F81F533-37F2-4416-A1A3-19ED58F8A0F9Q38116597-B0D3B284-7477-47EE-9A5A-D111566F4305Q38266162-63B0481A-94B5-4650-ABD1-2AF33656F531Q38547002-EA2B29C1-D578-4C38-8450-D40150088EBFQ38604245-E361D49F-B89E-437A-B743-F4B9F88806D2Q39646600-80DDB848-295B-4EDE-B4B0-B8A68D6D2CD9Q47233654-1758525A-E712-4682-97D1-3CB9D0F78257Q48186224-CFEBD9AB-12A4-47C7-8A6E-17B5980DD079Q50757557-09BB7906-6859-4C93-8640-42F25D8E2478Q52582071-F5BC93E5-C879-49F3-BF97-040364304EC7
P2860
Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Temporal lobe grey matter volu ...... synthase kinase 3-β activity.
@en
Temporal lobe grey matter volu ...... synthase kinase 3-β activity.
@nl
type
label
Temporal lobe grey matter volu ...... synthase kinase 3-β activity.
@en
Temporal lobe grey matter volu ...... synthase kinase 3-β activity.
@nl
prefLabel
Temporal lobe grey matter volu ...... synthase kinase 3-β activity.
@en
Temporal lobe grey matter volu ...... synthase kinase 3-β activity.
@nl
P2093
P50
P1476
Temporal lobe grey matter volu ...... synthase kinase 3-β activity.
@en
P2093
A Bernasconi
C Locatelli
E Smeraldi
P2860
P304
P356
10.1111/J.1601-183X.2010.00566.X
P407
P50
P577
2010-01-25T00:00:00Z